WINTON GROUP Ltd

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1612063 LONDON, X0

Position in PTGX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,334,160

-$1,574 QoQ

Shares Held

10,884

-14.1% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#166

of 341 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. PTGX ranks #17 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	254,408	$28,839,690
2	FTRE	Fortrea Holdings Inc.	389,155	$6,771,297
3	EXEL	Exelixis, Inc.	99,834	$5,431,967
4	TECH	BIO-TECHNE Corp	67,227	$4,749,587
5	HALO	Halozyme Therapeutics, Inc.	60,348	$4,723,437
6	VKTX	Viking Therapeutics, Inc.	90,546	$3,532,199
7	ALNY	Alnylam Pharmaceuticals, Inc.	7,880	$2,372,116
8	TRVI	Trevi Therapeutics, Inc.	106,852	$1,992,789

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,334,160	10,884	-14.1%	Shares	Sole	2026-08-07
2026-03-31	$1,335,734	12,673	+10.5%	Shares	Sole	2026-05-12
2025-12-31	$1,001,877	11,471	-38.2%	Shares	Sole	2026-02-11
2025-09-30	$1,233,007	18,561	+6.5%	Shares	Sole	2025-11-13
2025-06-30	$963,521	17,433	-16.2%	Shares	Sole	2025-08-14
2025-03-31	$1,005,646	20,795	-22.3%	Shares	Sole	2025-05-15
2024-12-31	$1,033,244	26,768	+3.0%	Shares	Sole	2025-02-12
2024-09-30	$1,169,235	25,983	+378.4%	Shares	Sole	2024-11-12
2021-06-30	$243,743	5,431	-83.5%	Shares	Sole	2021-08-10
2020-09-30	$642,295	32,854	-14.9%	Shares	Sole	2020-10-30
2020-06-30	$681,870	38,611	+2.2%	Shares	Sole	2020-08-05
2020-03-31	$266,747	37,783	—	Shares	Sole	2020-05-11
No filing history on record for this holder in this stock.